These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12230456)

  • 1. Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies.
    Souka AP; Raymond FL; Mornet E; Geerts L; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):294-5. PubMed ID: 12230456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe perinatal hypophosphatasia due to homozygous deletion of T at nucleotide 1559 in the tissue nonspecific alkaline phosphatase gene.
    Sawai H; Kanazawa N; Tsukahara Y; Koike K; Udagawa H; Koyama K; Mornet E
    Prenat Diagn; 2003 Sep; 23(9):743-6. PubMed ID: 12975786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation.
    Hyett J; Noble P; Sebire NJ; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 May; 9(5):310-3. PubMed ID: 9201873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal Mid-Gestation Fetal Ultrasonography Cannot Reliably Exclude Severe Perinatal Hypophosphatasia.
    Chinoy A; Iruloh C; Kerr B; Mughal MZ; Padidela R
    Horm Res Paediatr; 2021; 94(7-8):307-312. PubMed ID: 34438404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypophosphatasia: molecular testing of 19 prenatal cases and discussion about genetic counseling.
    Simon-Bouy B; Taillandier A; Fauvert D; Brun-Heath I; Serre JL; Armengod CG; Bialer MG; Mathieu M; Cousin J; Chitayat D; Liebelt J; Feldman B; Gérard-Blanluet M; Körtge-Jung S; King C; Laivuori H; Le Merrer M; Mehta S; Jern C; Sharif S; Prieur F; Gillessen-Kaesbach G; Zankl A; Mornet E
    Prenat Diagn; 2008 Nov; 28(11):993-8. PubMed ID: 18925618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific ultrasonographic features of perinatal lethal hypophosphatasia.
    Zankl A; Mornet E; Wong S
    Am J Med Genet A; 2008 May; 146A(9):1200-4. PubMed ID: 18386808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.
    Cha'ban FK; Van Splunder P; Los FJ; Wladimiroff JW
    Prenat Diagn; 1996 Jun; 16(6):537-41. PubMed ID: 8809895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal hypophosphatasia: radiology, pathology and molecular biology studies in a family harboring a splicing mutation (648+1A) and a novel missense mutation (N400S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene.
    Sergi C; Mornet E; Troeger J; Voigtlaender T
    Am J Med Genet; 2001 Oct; 103(3):235-40. PubMed ID: 11745997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for hemodynamic compromise at 11-14 weeks in monochorionic twin pregnancy: is abnormal flow in the ductus venosus predictive of twin-twin transfusion syndrome?
    Matias A; Ramalho C; Montenegro N
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):79-86. PubMed ID: 16203591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation.
    Hyett J; Moscoso G; Papapanagiotou G; Perdu M; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Apr; 7(4):245-50. PubMed ID: 8726875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
    Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
    Schaefer M; Laurichesse-Delmas H; Ville Y
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationship between increased nuchal translucency and enlarged jugular lymphatic sac.
    Bekker MN; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
    Obstet Gynecol; 2006 Oct; 108(4):846-53. PubMed ID: 17012445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of fetal position on nuchal translucency thickness.
    de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
    Hyett JA; Perdu M; Sharland GK; Snijders RS; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):242-6. PubMed ID: 9383874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
    Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
    BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia.
    Masturzo B; Hyett JA; Kalache KD; Rumsby G; Jauniaux E; Rodeck CH
    Prenat Diagn; 2001 Apr; 21(4):314-6. PubMed ID: 11288125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.